Skip to main content
. 2017 Jul 20;35(25):2934–2941. doi: 10.1200/JCO.2016.71.8726

Fig 3.

Fig 3.

Response of patients with BRAF V600E pediatric low-grade glioma to chemotherapy and BRAF V600E inhibition. Waterfall plot of response to chemotherapy at 6 months. Note the response to BRAF V600E inhibitors in gray. PFS, progression-free survival.